Beta Bionics(BBNX)
IRVINE, CABiotechnology
Focus: Beta Bionics is a public biotech company focused on artificial pancreas technology, specifically the iLet Bionic Pancreas system for diabetes management. The company operates at a small scale with 1-50 employees and recently achieved FDA clearance for its Mint patch pump in September 2026.
Profile data last refreshed 11h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Employees
1-50
Open Jobs
22-3 this month
Stable — net -3 jobs in 30d
11 added, 14 removed. Backfill posture.
Should You Work at Beta Bionics?
AI assessmentA high-risk, high-reward early-stage opportunity best suited for mission-driven professionals comfortable with startup volatility and willing to bet on a product-approved but pre-profitability company.
Why Work Here
- Recent FDA approval of Mint patch pump (September 2026) signals product-market validation and upcoming commercial ramp potential
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$65M
Pipeline & Clinical Trials
Help build intelligence for Beta Bionics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.